Information and news about disease category

, ,

Poverty and Malaria Vaccine Price Cuts

Poverty and MalariaMalaria remains one the world’s deadliest diseases, disproportionately affecting children in Africa. Global health organizations achieved a major breakthrough in the fight against this life-threatening infection in 2023 by rolling out the world’s first malaria vaccine: manufacturers have now slashed the price of this vaccine, along with a second approved vaccine, and it could be an important step in relieving the socioeconomic burden of the disease across the African continent.

In late 2025, Gavi, the Vaccine Alliance, and children’s agency UNICEF struck a pricing deal to cut the cost of the R21/Matrix-M vaccine to $2.99 USD from around $4. Analysts project that these reductions will unlock 30 million extra doses before 2030, protecting around 7 million children. This monumental pricing deal follows on from another cost reduction that Bharat Biotech and GSK announced in June of 2025, stating that they will progressively reduce the price of the RTS,S malaria vaccine by half, falling to less than $5 USD per dose.

A Crucial Vaccination Effort

Researchers initially struggled to develop an effective malaria vaccine: vaccines train the immune system to recognize proteins on the surfaces of infectious agents (e.g., bacteria, viruses). The infectious agent associated with malaria is Plasmodium falciparum, a parasite that can evade the immune system and change its surface proteins throughout its life cycle, thus finding a suitable vaccine to target the parasite became complicated.

When researchers achieved clinical breakthroughs in 2004 and refined a vaccine formula, it was time to move to human trials. The newly-named ‘RTS,S/AS01’ vaccine was administered to groups of young children across sub-Saharan Africa in the first rounds of human testing.

Trials ran from 2004 until 2015 and concluded that three doses of RTS,S was enough to reduce clinical malaria cases in children by up to 39%. In January 2024, a mass roll-out of the RTS,S vaccine began in Cameroon and authorities soon followed it with the distribution of the more cost-effective vaccine, R21/Matrix-M. Now, RTS,S and R21 vaccinations form part of routine childhood immunizations in more than 20 African countries, acting as a crucial tool for protecting children against deadly infections.

The Importance of Equitable Pricing in Immunization

Many factors influence the pricing of a vaccine introduced into the market, including patent protection, production cost and volume of contract. Notably, there is a positive correlation between a country’s Gross National Income (GNI) and the price point at which suppliers sell a dosage within the country- this is known as tiered pricing.

Rather than selling a vaccine at a flat rate, pharmaceutical companies use tiered pricing to charge high-income countries a higher price per dosage to balance affordability in lower-income markets, cover research and development (R&D) costs and generate profit. This improves the accessibility of vaccines regardless of geographical location and socioeconomic status.

However, malaria is a disease that primarily affects the Global South, therefore the market for the RTS,S and R21 vaccines for high-income countries in the Global North was almost non-existent. The typical vaccine development model and tiered pricing system could not be implemented, and external organizations, including the World Health Organization (WHO) and The Bill and Melinda Gates Foundation, filled the funding gaps.

The introduction of the second-ever malaria vaccine, R21, improved vaccine equity through accessibility: the formula has a lower concentration of antigens (the active ingredient in vaccines) whilst maintaining its efficacy, which drastically cuts manufacturing costs. Doses of R21 are better adapted to the African climate because of less strict requirements in cold chain storage and transport, reducing accidental wastage and ensuring more children receive protective immunization.

The Socioeconomic Impact of Immunity

The relationship between malaria and socioeconomic status can be considered bi-directional: malaria infection and recovery minimizes a person’s ability to work, attend school or perform caregiving duties, increasing the risk of experiencing poverty. Conversely, those living in poor conditions without access to adequate sanitation or health care face a higher risk of malaria infection and suffering more severe disease outcomes.

Therefore, immunity can break the cycle of poverty and malaria. As a whole, every $1 USD spent on vaccines saves between $16-44 USD on treatments and broader economic implications of disease. Driving down the price of each dose improves vaccine equity, ensuring that communities most affected by extreme poverty and seasonal malaria spikes will be among those protected.

However, immunization alone is not enough to decrease the malaria burden across the African continent. Research from Gavi, the Vaccine Alliance, demonstrates that the RTS,S vaccine is around 63% effective as a prevention tool, but when used in combination with insecticide-treated bed nets, indoor residual spraying and seasonal malaria chemoprevention (SMC), efficacy rises to 93%. Studies have shown that the malaria vaccine is least effective in children who come from low socioeconomic status households, this is likely due to a lack of health care access which prevents children from completing all three immunizations along with preventative SMC treatments.

What Will the Future of Malaria Vaccination Look Like?

More and more African countries are adopting affordable malaria vaccine strategies, and keeping this momentum will be the key to imagining a malaria-free future. Community engagement has proven to be a highly successful strategy in effort to relieve concerns regarding the vaccine’s safety and cost. In the early stages of vaccine roll-out in Cameroon, parents initially responded to the scheme with hesitancy: community and religious leaders drove up vaccine demand by encouraging open discussions at community meetings and disseminating misinformation. Following the success of Cameroon’s vaccination campaign, global health partners have adopted this person-led strategy by connecting with community leaders and technical experts directly.

Gavi has predicted that immunizing around 50 million children against malaria before 2030 could save more than 170,000 lives. An increasing number of children will have the opportunity to complete their education uninterrupted by disease and parents will be relieved of the costly burdens of caregiving and clinical treatments. African governments and communities have responded to the agreement to slash malaria vaccine prices with great optimism and will be a huge step in protecting the most vulnerable populations from poverty.

– Charlotte Bunn

Charlotte is based in Bristol, UK and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Melioidosis in Bangladesh Threatens Rural Communities

Melioidosis in BangladeshHidden beneath flooded rice fields and carried by monsoon rains, a little-known disease is shaping a quiet public health crisis. Melioidosis in Bangladesh exists at the intersection of climate, poverty and limited health care access. Yet it remains largely invisible in national disease statistics.

For many patients, the illness never earns its real name, instead slipping through the health care system disguised as more familiar conditions. Rural communities suffer the most severe consequences, as their livelihoods depend on daily contact with soil and water. Understanding why melioidosis continues to evade recognition is essential not only to saving lives but also to protecting the people who sustain Bangladesh’s economy and food security.

Misdiagnosed, Misrepresented and Misunderstood

Melioidosis manifests differently from person to person and can range in severity from flu-like symptoms to skin abscesses and sepsis. Burkholderia pseudomallei enters the body through ingestion, inhalation or skin cuts, allowing it to infect the bloodstream, lungs and skin, sometimes simultaneously. Because the bacteria can affect multiple organ systems, melioidosis is often misdiagnosed as tuberculosis, fungal infections or even cancer.

These misdiagnoses can delay treatment, even though antibiotics must be started promptly and completed fully to improve recovery outcomes. Since the ’60s, hospitals in Bangladesh have reported only around 100 cases of melioidosis. This figure is widely believed to underestimate the true burden of the disease.

One study estimates that melioidosis in Bangladesh could account for up to 17,000 cases and 9,500 deaths each year. This gap is mainly due to limited clinical awareness and insufficient laboratory capacity for proper diagnosis. Patients with other underlying conditions, known as comorbidities, are at a higher risk of melioidosis, including those with diabetes, alcohol use disorder and chronic lung disease, which may complicate diagnosis further.

Rural Communities in Bangladesh at High Risk

Burkholderia pseudomallei is well-adapted to Bangladesh’s warm, humid climate. The bacterium thrives in environments with year-round high temperatures, waterlogged soil and frequent monsoon rainfall. As a result, rural communities, particularly those dependent on agriculture, face the greatest risk of infection.

Agriculture accounts for nearly 90% of rural employment and many farmers work barefoot or without protective equipment, increasing their exposure through direct contact with contaminated soil and water. Social factors further compound the risk. Poverty rates in rural Bangladesh stand at around 20%, compared with 16.5% in urban areas.

Illness caused by melioidosis can prevent individuals from working, deepening economic hardship for affected families and communities. Looking more broadly, the agricultural sector is one of the most productive in Bangladesh’s economy, contributing around 11% of the national GDP. Rural farming communities sit at the heart of this system.

Yet, they often have the least access to health care due to geographic and financial constraints. Protecting farmers and their families from melioidosis, therefore, supports not only their health and livelihoods but also the country’s food security and export capacity. This underscores the need for adequate protective equipment and timely access to effective antibiotic treatment.

Fighting for Futures: The South Asian Melioidosis Congress

In 2023, the third South Asian Melioidosis Congress (SAMC) met in Dhaka, Bangladesh, to discuss emerging research concerning the tropical disease and to share methods of its detection and management. These educational meetings aimed to raise awareness of melioidosis and provide physicians with the tools for accurate diagnosis. This proved successful, with nine reported cases of melioidosis in Bangladesh soon after the SAMC’s conclusion, each patient with different symptoms.

This reflects the vigilance of health care professionals regarding the early diagnosis of melioidosis as empowered by the collective effort of the SAMC to fight this disease. Following the conclusion of the fourth SAMC at the end of 2025, organizers are hopeful that renewed awareness will lead to more diagnosed cases being reported in Bangladesh. The theme of the fourth SAMC, “Melioidosis: The Great Mimicker,” highlighted the disease’s ability to mimic a wide range of illnesses.

The most recent congress brought together experts from across the world in Northeast India to discuss key issues surrounding melioidosis, including diagnostic approaches, public health implications and treatment guidelines. These discussions aimed to raise awareness of the disease and strengthen future efforts to protect vulnerable rural communities.

– Charlotte Bunn

Charlotte is based in Bristol, UK and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

5 Diseases Impacting Myanmar

Diseases Impacting MyanmarMyanmar is a nation of more than 100 ethnic groups, yet the Rohingya genocide has brought attention to the country’s corrupt military takeover from 2021. Due to the poor living conditions in the country and the current climate crisis, the diseases impacting Myanmar run rampant, but these are not just medical problems. They are symptoms of a broken health care system that conflict, repression, displacement and underfunding have weakened. However, the combined effort of international aid and volunteering has allowed some solutions to this health crisis. Here is information about five diseases that are impacting Myanmar.

5 Diseases Impacting Myanmar

The communicable diseases impacting Myanmar include:

  • Tuberculosis: The incidence rate of TB was 558 per 100,000 population in 2023 and close to 50,000 deaths are as a result of the disease in Myanmar. Treatment interruptions have increased drug-resistant TB, yet NGOs are still using community-based treatment. More than 3.5 million internally displaced people and worsening poverty have increased TB vulnerability. In 2024, Doctors Without Borders helped 480 people start treatment for TB, with 981 staff in Myanmar providing health care services.
  • Malaria: In 2023, there were 229,000 cases of malaria in Myanmar. Cases are resurging in conflict areas, despite proven interventions such as bed-net distribution, rapid testing and cross-border health programs. However, Myanmar aims to eliminate the transmission of malaria cases by 2030, and 126,562 patients received treatment between January and August 2025, according to Deputy Minister for Health, Professor Dr Aye Tun. 
  • HIV/AIDS: Disrupted access to antiretroviral therapy places lives at risk, even though mobile clinics have proven effective. In 2023, 0.9% of people aged between 15 and 49 suffered from HIV, with 5,800 of them dying. These diseases are not just affecting older people, but children and young adults, as well as people in detention.
  • Dengue Fever: Rising infections linked to poor sanitation highlight the need for investment in water, waste management and disease surveillance. Myanmar is a country with frequent and continuous risk of dengue, especially due to seasonal changes. In 2019, dengue fever mostly infects children aged between 5 and 9 years old with 4,473 cases registered. The Ministry of Health tries to combat dengue by killing mosquito larvae, then fogging houses near patients to eliminate mosquitoes.
  • Cholera/Diarrheal Diseases: Cholera is a waterborne disease that has surged in at least nine states in Myanmar since 2024. Around 300 people reported suffering from a cholera outbreak in late 2025, with seven confirmed dead. These people include vulnerable children without safe water or living conditions. Emergency WASH (Water, Sanitation and Hygiene) interventions that international donors support can address conditions.

Chronic Illnesses

Chronic illnesses such as diabetes, hypertension, heart disease and cancer are fatal for these people, because hospitals are underfunded, medicines are unavailable and travel to care is dangerous. Expanding access to health care, essential medicines lists and decentralized treatment is critical. Myanmar remains one of the world’s most underfunded humanitarian operations, receiving less than $136 million in 2025 of the $1.1 billion it needs.

The Relationship Between Poverty and Disease in Myanmar

In developing countries like Myanmar, preventative medicines and measures can be obtained by the wealthy, but this means that often, families without enough money face higher risks of dying from avoidable disease. Whilst in developed countries, the elderly are more likely to face these diseases, in Myanmar, people younger than the age of 70, and even children are suffering from both communicable and non-communicable diseases, due to the disparity between the country’s rich and the poor. Nearly 32% of the country lives in poverty. Poverty and disease in Myanmar share a symbiotic relationship, especially considering that after the 2025 earthquake, many people are living in tents, allowing outbreaks of cholera and other waterborne diseases to occur.

Solutions

There have been developments however. The Republic of Korea made a generous contribution to UNICEF to help families and the vulnerable in Myanmar, especially considering that one-third of more than 3.5 million displaced are children.

Organizations like Doctors Without Borders are trying their best to support Myanmar’s health care. Following the 2025 earthquake, it has restored more than 200 bore holes, supplied hospital beds and been trying to aid victims of serious diseases. Following the 2021 military coup, Doctors Without Borders donated medical supplies to Yangon and other locations. The success of help like this is demonstrated in the case of Ko Tin Maung Shwe, a patient suffering from HIV and hepatitis C. With hospitals being destroyed and the fear of travelling, Doctors Without Borders are helping patients like him with blood tests, consultations and medication. As well as this, it is expanding access to psychosocial support.

All of this help is essential because the ongoing conflict in Myanmar by the military regime has damaged civilian infrastructure and in 2023 alone, more than 418 attacks on health care had occurred. Alongside the violence, the climate crisis that has caused major earthquakes in Myanmar has led to an increase in the number of vulnerable people suffering from disease.

How Is the World Aiding Myanmar?

In 2025, the U.K. announced additional humanitarian funding to provide health care to 1 million people across Myanmar. The then Minister for Development, Anneliese Dodds, underscored this commitment by stressing that the U.K. would not abandon the people enduring a brutal conflict – one that has fueled a humanitarian emergency in a country already exposed to the impacts of changing weather patterns. This assistance has extended beyond the Rohingya community, supporting vulnerable populations nationwide, particularly in the aftermath of the 2025 Myanmar earthquake. Despite this, Donald Trump’s USAID cuts have severely limited the amount of health care support that exists, but countries within the EU, as well as NGOs like UNICEF, are still trying to help the crisis in Myanmar. UN agencies are committed to helping affected populations in Myanmar, proven by the fact that in July 2025, nearly 306,000 people across 59 earthquake-hit townships received health services.

Looking Ahead

People in Myanmar are in desperate need of humanitarian aid. They are not just suffering from war injuries, but they are also dying from illnesses that the international community already knows how to treat. The diseases impacting Myanmar are more than humanitarian crises, they are symbols of injustice, repression and perhaps even hope – hope that once the world understands how much the vulnerable people need help, they will act.

– Anisa Begum

Anisa is based in Birmingham, UK and focuses on Global Health for The Borgen Project.

Photo: Unsplash

, ,

Diseases Impacting Libya: Top 3 Factors Affecting Health Care

Diseases Impacting LibyaLocated in the north of Africa between Algeria and Egypt, Libya has a population of about 7.5 million people, most of them concentrated in urban, coastal cities like Tripoli and Benghazi. The World Health Organization (WHO) identified cholera and polio as very high risk diseases to impact Libyans in 2025. Other non-communicable diseases such as cancer are also threatening many individuals because of how expensive and difficult it is to get treatment. Here are the top three factors affecting health and safety, including access to health care and diseases impacting Libya.

1. Climate and Changing Weather Patterns

Libya is one of the world’s most arid countries. It witnesses periods of extreme heat, droughts and violent rain and dust storms. These acute weather conditions compromise health and safety, as access to potable water becomes more scarce and food insecurity spikes.

In September 2023, cyclone Daniel made a bad situation worse in terms of diseases impacting Libya, with flooding and damages to already deteriorating infrastructure including health and care facilities in Derna. Water contamination and lack of sanitation were top reasons for health concerns as storms also destroyed two dams upstream of the city. In the immediate aftermath of the storm, medical professionals were most concerned about potential cholera and acute watery diarrhea (AWD) outbreaks. As of October 3, 2023, the National Center for Disease Control (NCDC) reported 1,905 cases of AWD.

2. Sudanese Migration 

A war-torn Sudan has led many to flee and seek refuge in its neighboring countries. Since April 2023, cities like Al Kufra in Eastern Libya saw an influx of somewhere close to 500 Sudanese migrants passing through each day. Such a high number of refugees has led to issues like overcrowding, especially in settlements, which in turn could lead to an increase in diseases impacting Libya. 

Those arriving from conflict zones are often in ill-health. Be it communicable diseases or in poor mental-health, many have not had access to vaccinations or other preventative treatments that could avoid medical emergencies like outbreaks. Officials like WHO are most concerned about a cholera epidemic, though tracking its spread will prove difficult for lack of testing facilities and resources.

3. The Government

Since the 2011 Revolution, Libyans have witnessed waves of political fragmentation, tension and violence. The persistent conflict caused years of neglect in the health care system, ultimately resulting in inconsistent health care services for Libyans.

Opposing governments and factions fighting for power have divided the country, making it difficult, if not impossible, to coordinate with health care professionals and NGOs on the ground to establish clinical practice guidelines that would prevent outbreaks and efficiently combat diseases impacting Libya. 

Then, in April 2025 the Internal Security Agency (ISA) based in Tripoli announced the shutdown of headquarters of 10 major NGOs, including MSF, for compromising Libya’s social demographic and for promoting values that go against Libyan identity. MSF reported at least six known casualties in the weeks since it had to pull its aid, and expect the order to have more consequences on their patients that they will not be able to track due to loss of contact.  

Who’s Helping?

After Cyclone Daniel, organizations such as UNICEF, the Red Cross, the World Food Programme (WFP) and the International Medical Corps (IMC) sent immediate relief. This included, for example, renovating 25 health facilities, training more than 1,100 health care providers and distributing food to more than 15,000 people. 

Though the 10 humanitarian organizations ordered to leave Libya in April 2025 have not been allowed to return to date, there are still other groups present in the country. The International Medical Corps (IMC), for example, provided more than 27,000 medical consultations and helped countless refugees back on their feet as of July 2025. The European Union (EU) continues to fund aid in correspondence with WHO, Première Urgence Internationale and the IMC. In 2025, the EU funded €3 million in response to mass Sudanese migration. 

Given the inconsistency in health care provisions, NGOs on the ground are doing significant work for Libyans and refugees. There is still much work to do. Providing medical aid and investing in care facilities is just scratching the surface. Without addressing the climate crisis, the lack of accommodation for refugees and government fragmentation, health and safety will remain compromised and diseases impacting Libyans will continue to risk lives. 

– Brittany Buscio

Brittany is based in Montreal, Canada and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Dangerous Diseases Impacting Djibouti

Diseases in DjiboutiThe residents of Djibouti face many challenges. Natural factors such as drought and higher temperatures affect not only residents’ basic needs but also their quality of life with disease and poverty distressing the population constantly. Here is information about some of the diseases impacting Djibouti.

Diseases Impacting Djibouti

Diseases impact the majority of communities in Djibouti. These are examples of some of the most severe illnesses harming vulnerable members in society. Both communicable and non-communicable diseases are threatening.

  • Malaria
  • Human Immunodeficiency Virus (HIV)
  • Cholera
  • Tuberculosis
  • Hepatitis B 

How Effective Is Medical Care in Djibouti?

Health centers are limited. This is attributed to a lack of staff and resources, which impacts Djibouti’s health care system. Medical systems are strained from pressure and the heavy disease rate.

There is a substantial divide in medical care between rural and urban areas. Urban areas are more likely to have a stronger infrastructure and more funding. Djibouti has 66 medical centers and most of them are located in the capital, Djibouti City. Peltier Hospital is the biggest hospital there, which is not only a place to treat disease, but also home to medical discoveries as research takes place there.

Poverty in Djibouti

A main cause of Djibouti’s hardships is because of poverty, which one can see through its medical care. Even though public health care costs less and is easier for people to access in Djibouti compared to private health care, there are lengthy wait times and staff shortages. Meanwhile, private health care has shorter wait times and more advanced staff.

About 79% of people in Djibouti live in poverty but 42% live in the most extreme conditions. Health care is a constant battle due to people lacking income and having a constant threat of disease. As private health care is more costly, most of the population cannot afford it.

Malaria and Genetically Engineered Mosquitos

Malaria is an ongoing issue in Djibouti. In the year of 2012, 27 cases took place but over the following years to 2020, it has dramatically grown to above 73,000. 

These statistics show how malaria is an increasing issue. Malaria is spread when a mosquito is infected and bites a living organism. This is not communicable, but the infection spreads in the blood stream. The cycle continues as a mosquito will bite the infected person and it resumes. In rare cases, people can catch it through blood transfusions.

In 2024, tens of thousands of genetically engineered mosquitos were created to mitigate the spread of infection thanks to Oxitecs Friendly™. The male mosquitos carry a gene that kills the female mosquitos, reducing malaria. Only female mosquitos carry the disease, so reducing them mitigates the spread of malaria.

HIV and Mobile Brigades

More than 1% of local people are diagnosed with HIV. This is classed as a high rate, underlining the conditions people of Djibouti experience daily. This chronic condition is a virus, that harms the immune system.

HIV passes from person to person through close contact with bodily fluids. Unfortunately, there is no current cure, but treatment can help. If it is not quickly treated, it can develop and become more serious.

Djibouti faces the harshest realities of poverty and this heightens HIV rates. Due to a lack of funding and awareness into health care, more people will unfortunately suffer. Women are more vulnerable to this because they are fearful to reach out for help to help end HIV. This is because of the negative stigma attached to HIV/AIDS.

However, new developments are emerging to reduce the negative stigma. One example is mobile brigades. These are vehicles with medical professionals that go to communities, test for HIV and bring awareness. In 2019, they raised awareness of HIV/AIDS to about 26,000 people who were at risk. Additionally, the mobile brigades provided 6,000 tests and treatment to 2,900 people.

Addressing Cholera

Another of the diseases impacting Djibouti is cholera. Cholera is a disease that is bacterial and passes through contaminated food sources. Cholera can cause stomach pain, sickness, dehydration and death in some severe cases. 

The latest cholera outbreak that Djibouti considered a threat was in 1893. However, the country continued to view cholera as high risk in 2007, and it is significantly dangerous for children. This is because children with cholera often do not show symptoms and fatalities can come about quietly.

UNICEF is implementing WASH interventions in several countries across the globe to eliminate cholera and Djibouti is one of its target countries. Some strategies include implementing reliable and safe water sources and medical treatments, and improving hygiene practices.

The Impact of Tuberculosis

There are around 40 to 499 cases every 100,000 people of the Djibouti population. Tuberculosis is a bacterial infection that is passed from one infected person to the other. This occurs through direct encounters as people can get it through contact with a contaminated person.

The statistics show that this disease is a persistent problem. This is reflected through safety information, as travelers are advised to do screening for their safety and others. This highlights the importance of medical care. Fortunately, it is a curable disease, although if not treated, it can be fatal.

The Prevalence of Hepatitis B

Hepatitis B is a virus that can cause liver issues and is another of the diseases impacting Djibouti. Depending on its severity, it can either be short term or long term. Hepatitis B is spread through bodily fluids or infection spread through blood.

Many see Hepatitis B as a prevalent issue because there is no cure. However, vaccines and treatments can reduce the possibility of Hepatitis B. According to recent data, out of every 100,000 people of the population of Djibouti, 1,044.47 people are diagnosed with Hepatitis B. The statistic is considered high. Sometimes people can be a carrier of it without their knowledge, making it more dangerous.

Looking Ahead

Overall, disease impacts all parts of life in Djibouti. With the hardships of natural disasters and lack of funding, poverty still continues to be the main issue. Funding gives access to medical care and education, and a better life for people of Djibouti. However, with more awareness, this can happen. The new medical achievements show a more positive future for the Djibouti nation.

– Daisy Maidment

Daisy is based in Manchester, UK and focuses on Global Health for The Borgen Project.

Photo: Wikimedia Commons

,

The Maldives’ Triple Elimination: A Blueprint for Health

Maldives’ Triple EliminationIn October 2025, the World Health Organization (WHO) announced that the Maldives’ historic triple elimination of mother-to-child transmission of Human Immunodeficiency Virus (HIV), syphilis and hepatitis B had been officially validated. This certification makes the Maldives the first country in the world to successfully eliminate the transmission of all three life-threatening diseases from mother to child simultaneously. The milestone represents a major triumph for maternal health and provides a clear strategy for other low- and middle-income countries (LMICs) to follow.

Understanding Triple Elimination

Triple elimination is a public health standard that ensures the next generation is born free of three specific infections that often cause lifelong health complications or infant mortality. To achieve this, the Maldives had to meet rigorous WHO criteria, including maintaining antenatal care coverage and testing rates above 95%. The nation also proved that its newborn interventions, such as the hepatitis B birth dose, are consistently delivered within 24 hours of birth. Data show that the Maldives recorded zero babies born with HIV or syphilis in both 2022 and 2023. Additionally, a national survey in 2023 confirmed that no young children entering school carried hepatitis B.

A Decentralized Approach to Maternal Care

Progress toward the Maldives’ historic triple elimination was made possible by a decade of systemic reform focused on reaching people in remote areas. Because the population is dispersed across more than 1,000 islands, the government prioritized a decentralized, community-based health care system. In 2018, the nation implemented the “Agenda for Integrated Service Delivery,” which standardized data collection for all three diseases. This ensured that even on the smallest islands, pregnant women could access free testing and treatment. By removing financial barriers, the government addressed a primary cause of health vulnerability among low-income families.

The Role of WHO and United Nations Children’s Fund (UNICEF)

The WHO and UNICEF played essential roles in supporting the Maldives during the validation process. The WHO provided the technical framework and training to ensure that screening and vaccination programs were integrated into routine maternal and child health services. UNICEF South Asia contributed by reviewing and refining national reports to ensure they met global standards for data accuracy. These organizations worked alongside the Indira Gandhi Memorial Hospital, which serves as the national reference laboratory for validating test results. This partnership allowed the Maldives to use digital monitoring tools such as the Electronic Immunization Registry to track children’s health status in real time.

Promoting Equity With the Migrant Health Policy

The path to the Maldives’ historic triple elimination also involved ensuring that no resident was left behind due to background or legal status. The government recently launched a Migrant Health Policy that guarantees equal access to health services for all residents, including migrant populations. This inclusive policy reduced gaps in disease surveillance and ensured that every mother living in the country received the same standard of care. Experts note that including marginalized groups in national health frameworks is a critical factor in achieving disease elimination goals.

A Beacon of Hope for Global Health

The success of the Maldives serves as a beacon of hope for other nations working to eliminate preventable infections. By combining political leadership with a decentralized health system and strong international partnerships, the country has protected future generations from chronic disease. The Maldives’ historic triple elimination demonstrates that geographic isolation and resource constraints are not insurmountable barriers to public health progress. As countries move toward the 2030 global goal for triple elimination, the Maldives shows that equitable, high-quality health care can play a significant role in reducing poverty and improving lives.

– Elena Cárdenas

Elena is based in Monterrey, México and focuses on Global Health and Politics for The Borgen Project.

Photo: Flickr

, ,

Ending the Ebola Outbreak in the DRC

Ebola Outbreak in the DRCOn Dec. 1, 2025, the Democratic Republic of Congo’s (DRC) Ministry of Health declared the end of the Ebola outbreak that occurred in Kasai Province. Since 1976, this was the 16th outbreak recorded in the country. The outbreak first occurred in the Bulape Health Zone and was declared on Sept. 4, 2025. A total of 64 cases were reported, with 45 deaths and a case fatality rate of 70.3%.

The urgent national and international response, including surveillance, case management, vaccination and community engagement, achieved successful containment of the disease. The outbreak occurred in a rural, hard-to-reach area with poor roads and limited infrastructure. The response illustrates how effective disease control safeguards vulnerable populations, minimizes economic disruption and supports poverty reduction while strengthening health systems in low- and middle-income countries. The last Ebola patient was discharged on Oct. 19, 2025, in Bulape, triggering the required 42-day countdown before officially declaring the outbreak over. Since Sept. 25, 2025, no new Ebola cases have been reported.

National Response and Vaccination Campaign

The leadership of the DRC government and the Ministry of Health led to a rapid response to the Ebola outbreak. Pre-existing agreements with vaccine manufacturers ensured immediate availability, and Gavi, the Vaccine Alliance, played a vital role in delivering 300,000 investigational doses of the rVSV-ZEBOV Ebola vaccine. As a result, ring vaccination was rapidly implemented on Sept. 14, 2025, in the Bulape Health Zone, focusing on high-risk contacts and frontline health workers. The World Health Organization (WHO) and Médecins Sans Frontières (MSF) also contributed operational support.

A total of 112 WHO experts and frontline responders were deployed to support field operations, and more than 150 tons of medical supplies and equipment were delivered to safeguard health workers and communities. Strong government coordination and decision-making also resulted in the introduction of an Infectious Disease Treatment Module (IDTM) to deliver higher-quality patient care while enhancing health worker safety. As a result, more than 47,500 people were vaccinated against Ebola.

The United Nations Children’s Fund (UNICEF) also played a vital role in preserving vaccine cold chain integrity in a region with limited infrastructure while working in close partnership with the DRC Ministry of Health, WHO and other United Nations (U.N.) agencies. Beyond vaccination, UNICEF supported medical care for Ebola patients, strengthened hygiene measures in schools and health facilities and delivered community education on disease prevention. Operational challenges were addressed by improving access to clean water at Bulape Hospital through the installation of a piped water system, delivering lasting benefits for both the facility and the wider community. The coordinated response halted transmission, minimized secondary infections and enabled the outbreak to be declared over.

Treatment Center and Clinical Efforts

The establishment of a new treatment center in Bulape supported the successful management of the Ebola outbreak. The 32-bed facility has been operational since Oct. 9, 2025, and was built on a 4,500-square-meter site located 200 meters from Bulape General Hospital. The center features 14 tents with private rooms to ensure patient dignity and privacy. Patient monitoring systems allowed staff to provide care without direct exposure to the disease, clearly separating “red zone” (high-risk) and “green zone” (low-risk) areas for safer workflow. The center also included a water, sanitation and hygiene system with a 20,000-liter capacity supplied from a protected source 1.2 kilometers away.

Another key innovation was the introduction of the Infectious Disease Treatment Module (IDTM) to provide more humane care. The module included the use of a “patient liner,” which allows constant patient visibility while maintaining safety, and a deliberate shift in language to emphasize dignity by referring to people as “patients” rather than “cases” and facilities as “treatment centers” instead of “isolation centers.”

In terms of staffing, 50 health professionals and 75 hygienists were trained, all staff were vaccinated and 64 WHO experts were deployed.

As a result, continuous collaboration between the Ministry of Health, WHO, Africa CDC and NGO partners made timely access to treatment and vaccines critical to reducing fatalities and stopping the outbreak. The WHO Africa director, Dr. Mohamed Janabi, said, “The recovery of the last patient … illustrates the strength of partnership, national expertise and collective determination to overcome obstacles to save lives.”

Looking Ahead

The successful containment of the Ebola outbreak in the DRC demonstrates the strength of coordinated public health action, effective partnerships and community engagement. Beyond ending transmission, the response improved preparedness, strengthened health systems and built community resilience. This achievement reinforces regional health security and reflects the DRC’s growing capacity to respond effectively to future outbreaks.

– Angela D’Avino

Angela is based in Preston, UK and focuses on Good News and Global Health for The Borgen Project.

Photo: Pixabay

, ,

GPEI Funding: $1.9 Billion Toward the Fight Against Polio

Fight Against PolioPoliovirus is a highly infectious viral disease that attacks the nervous system and could lead to paralysis or even death, mainly affecting children. Today, the virus mainly affects Afghanistan and Pakistan, along with other developing nations. The Global Polio Eradication Initiative (GPEI) is a partnership between the World Health Organization (WHO), Rotary International, U.S. Centers for Disease Control and Prevention (CDC), the United Nations Children’s Fund (UNICEF), the Gates Foundation and Gavi, the Vaccine Alliance that works to eradicate polio completely.

On December 8, 2025, it was announced that political leaders had collectively pledged $1.9 billion to the GPEI. In the fight against Polio, this generous fund has the potential to protect hundreds of millions of children from polio each year and possibly eradicate the virus.

How Polio Affects the World Today

Afghanistan and Pakistan remain the only countries where vaccines have not eliminated wild poliovirus. Other developing nations with low immunization rates continue to experience outbreaks of virus variants. This year, there have been 39 paralysis cases across Pakistan and Afghanistan.

Although polio cases are currently rare, “failure to stop polio in these last remaining areas could result in a global resurgence of the disease.” It is important to eradicate this virus in order to prevent it from spreading once again. Efforts have come very close to eradication and the recent GPEI funding will help bring the world even closer to this goal.

Successes in the Fight Against Polio

The GPEI was established in 1988 with the goal of ensuring that every child receives a polio vaccination. Since then, polio cases have dropped by 99% and vaccines have prevented approximately 20 million cases of paralysis. The virus once affected thousands of children across more than 100 countries but has now been eliminated in all except two, Afghanistan and Pakistan, where only a handful of cases occur each year.

About the Funds Against Polio

Pledges to the GPEI came from multiple donors, including:

  • $1.2 billion from the Gates Foundation
  • $450 million from Rotary International
  • $140 million from the Mohamed bin Zayed Foundation for Humanity
  • $100 million from Bloomberg Philanthropies
  • $154 million from Pakistan
  • $62 million from Germany
  • $46 million from the United States
  • $6 million from Japan
  • $4 million from the Islamic Food and Nutrition Council of America (IFANCA)
  • $3 million from Luxembourg

These funds will help protect 370 million children from polio through vaccination and reduce GPEI’s remaining resource gap. The shortage of vaccines and resources is a key reason polio still persists. With this recent funding, the complete eradication of poliovirus could become achievable.

– Renata Hirmiz

Renata is based in San Diego, CA, USA and focuses on Global Health for The Borgen Project.

Photo: Unsplash

, ,

ASPIRE in Haiti and Community-Driven Development in Myanmar

ASPIRE in HaitiThe onset of this decade has been marked by a surge in conflicts worldwide, with the number of conflicts and related fatalities having more than tripled since the early 2000s. These intensifying conflicts are causing severe and long-lasting economic damage. Currently, there are 39 economies classified as fragile and conflict-affected situations, with more than half of them facing active conflict. Due to the escalation of conflicts, global poverty and food insecurity are predominantly concentrated in these economies.

Poverty and Conflict

In these economies, close to 40% of the population lives in extreme poverty. According to the 2024 Global Multidimensional Poverty Index, out of 1.1 billion people living in acute poverty, 455 million resided in countries experiencing war or fragility. In 2025, although these regions accounted for less than 15% of the world’s population, they were home to 421 million people living in extreme poverty, more than the total in the rest of the world. Estimates indicate that by the end of this decade, nearly three-fifths of the global extremely impoverished population, approximately 435 million people, will be living in these economies.

As the conflict has intensified, food insecurity has also risen sharply, with approximately 200 million people, accounting for 18% of the population in these regions, facing acute food insecurity. Countries affected by conflict often experience high levels of poverty and ongoing conflict slows progress in poverty reduction. Poverty, in turn, interacts with other underlying grievances to fuel instability, while conflict further deepens economic hardship.

United Nations Security Council

At a United Nations Security Council open debate in New York, U.N. Secretary-General António Guterres emphasised how poverty can fuel conflict.

He said: “Poverty breeds despair. Despair fuels unrest. And unrest tears at the fabric of societies — feeding mistrust, fear and violence.” Conflict, in turn, weakens already weak institutions and exacerbates poverty and food insecurity. In cases of severe conflicts, after five years, the GDP per capita drops by around 15%. It has also negatively impacted employment creation and average life expectancy.

In this manner, conflict and poverty become mutually reinforcing, creating a vicious cycle. A World Bank report suggests that although these countries face significant challenges, they have untapped potential that could reignite growth with effective policymaking. One such advantage is having a large working-age population. By 2055, around 60% of the population in areas affected by conflict or instability will be of working age, larger than anywhere else in the world.

Transforming this into growth would require investment in education, health care, infrastructure and the private sector to create employment opportunities.

Breaking the Cycle

The World Bank, through its programs, aims to provide basic services, foster development opportunities and create employment in these economies by remaining engaged during conflict and after to assist in recovery and transition. The Adaptive Social Protection for Increased Resilience Project (ASPIRE) in Haiti and the National Community-Driven Development Project in Myanmar are two notable examples.

The ASPIRE program in Haiti supports nearly 23,000 households in the department of Grand’Anse. As Haiti continues to struggle with conflict and political instability, the initiative helps strengthen its ability to cope with recurring shocks by providing it with a monthly cash transfer. The program also aimed to provide training on financial literacy and health and hygiene practices to 50% of households. It helped identify more than 100,000 vulnerable households, enabling targeted investments. It not only addressed immediate challenges but also laid the groundwork for future investments in human capital.

The National Community-Driven Development Project in Myanmar, which comprised 37,000 sub-projects, positively impacted more than seven million people in the country. Nearly a fifth of the country’s population benefited from the improved infrastructure, transportation, water supply, education and electrification. Although the World Bank halted the disbursements of the Myanmar Partnership Multi-Donor Trust Fund in 2021, it continued to monitor the situation and provide analyses.

Final Remarks

Addressing conflict can lead to growth only when immediate humanitarian needs are met and paired with long-term investment in human capital. Through the ASPIRE program in Haiti and the development project in Myanmar, the World Bank routed investments toward education, health care and infrastructure. In doing so, the World Bank sought to break the vicious cycle of conflict and poverty.

– Priya Doshi

Priya is based in Edinburgh, Scotland and focuses on Good News and Politics for The Borgen Project.

Photo: Wikimedia Commons

,

How AI Systems Are Predicting Outbreaks of Malaria in Ghana

Malaria in GhanaMalaria remains a major public health challenge in Africa, causing about 95% of the continent’s malaria-related deaths. Malaria impacts many African countries, including Ghana, where pregnant women and children under 5 face the highest risk because of their lower immunity. The disease affects millions each year and deepens poverty by placing heavy financial pressure on vulnerable rural households.

Traditional malaria tracking methods often create delays because they rely on slow reporting and limited surveillance tools, which prevent health officials from responding quickly to rising cases. Recently, Ghana has begun integrating artificial intelligence into its disease surveillance systems to enhance malaria control. AI-powered malaria prediction systems, such as the District Health Information Management System (DHIMS2) and the Noguchi Memorial Institute for Medical Research (NMIMR), collect real-time health data and conduct malaria surveillance. These systems use climate information, satellite images and health reports to predict outbreaks.

Background

Ghana, located in West Africa and home to about 33.8 million people, shares borders with Burkina Faso, Ivory Coast and Togo. Historically known as the Gold Coast due to its abundant gold resources, Ghana has played a significant role in Africa’s development. Despite this history, malaria continues to affect the country heavily.

Ghana ranks among the top 15 countries with the highest malaria burden, accounting for about 5.3% of all malaria cases in West Africa. Ghana’s tropical climate provides perfect conditions for mosquitoes to breed rapidly, resulting in year-round malaria transmission. However, over the years, Ghana has introduced various malaria control strategies, ranging from early treatments such as chloroquine and quinine to modern interventions.

These include artemisinin-based combination therapies (ACTs), insecticide-treated bed nets and indoor residual spraying. Even with these efforts, malaria continues to strain Ghana’s health care system. Rural communities often submit reports late, struggle to access prevention tools and face drug resistance—factors that reduce the effectiveness of malaria control. These ongoing challenges have pushed Ghana to adopt AI-powered malaria prediction systems to strengthen early detection and reduce malaria cases.

AI-Driven Malaria Prediction Tools in Ghana

AI gives Ghana a more accurate and efficient way to understand and manage malaria. AI enhances data processing, health record management, feature identification, machine learning analysis, geospatial mapping and technical infrastructure—tools that aid researchers in studying malaria patterns more effectively. In recent years, Ghana has expanded the use of advanced AI-powered malaria prediction systems, such as the DHIMS2 and AI models developed by the NMIMR. These tools represent a major shift toward proactive, technology-driven malaria prediction.

DHIMS2

DHIMS2 serves as Ghana’s national digital health information management system, enabling health workers to collect and analyze data for enhanced health care management. Hospitals and clinics across the country upload information, including confirmed malaria cases, test results, treatment records and patient demographics. Because health workers enter data continuously, researchers and health officials can quickly identify unusual increases in malaria cases, rather than waiting for the slow processing of paper-based reports.

The platform covers every region, which helps experts create malaria risk maps, track seasonal changes and train AI models that forecast new outbreaks. By delivering fast and accurate data, DHIMS2 enhances Ghana’s ability to respond to malaria trends in real-time.

Noguchi Memorial Institute’s AI Surveillance Models

The NMIMR enhances malaria surveillance by gathering detailed data on mosquitoes, climate conditions and local disease patterns. Supported by a $3.5 million USAID grant, Noguchi researchers study malaria parasites, mosquito resistance and transmission trends.

The organization’s work contributes to the development of geospatial risk-mapping tools that combine health data with environmental factors, including rainfall, humidity, aridity and access to health care. These models help identify communities with a higher risk of malaria. Noguchi researchers also build on earlier studies that explore how climate conditions and mosquito behavior influence the spread of malaria. By producing this critical data, the NMIMR enhances Ghana’s early warning systems and improves malaria prediction.

Looking Ahead

As Ghana expands its use of AI-powered malaria prediction systems for malaria control, the country moves toward a more efficient and responsive public health system. Improving internet access, data accuracy and digital training for health care workers will further improve the effectiveness of AI tools. Partnerships with research institutions, technology companies and global health organizations will enhance Ghana’s ability to predict outbreaks in different regions.

With continued investment, Ghana can detect malaria risks earlier, direct resources to communities that need them most and reduce the incidence of new infections. Indeed, by embracing AI-powered solutions, Ghana can become a leader in modern malaria control and make significant progress toward long-term malaria reduction.

– Emmanuel Fagbemide

Emmanuel is based in Winnipeg, Canada and focuses on Technology and Global Health for The Borgen Project.

Photo: Unsplash